BioSpace News Archive

The Insight Partners published latest research report on “Respiratory Inhalers Market Size Report, Share, Trends, Growth and Revenue Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, and Disease Indication” the global market size is expected to grow from USD 31,144.56 million in 2022 to USD 43,446.19 million by 2028; it is estimated to record a CAGR of 5.7% from 2022 to 2028.

SomaLogic, Inc., a leader in proteomics technology, today announced that it will report financial results for the first quarter 2023 after market close on Thursday, May 11, 2023.

Biora Therapeutics, Inc. (Nasdaq: BIOR) today announced that it will participate in IBD Innovate: Product Development for Crohn’s & Colitis, an event hosted by the Crohn’s & Colitis Foundation to showcase innovative product development programs in inflammatory bowel disease (IBD), which will take place in New York City on April 26, 2023.

Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) (“Vallon” or the “Company”) today announced that its stockholders have approved Proposals 1, 2, 4 and 5, related to the previously announced proposed merger with GRI Bio, Inc., a privately held biotechnology company (“GRI Bio” or “GRI”), at a special meeting of stockholders held on April 20, 2023 (the “Special Meeting”).

On April 17, 2023, ImmVira announced the appointment of Dr. Oliver Kong as Chief Medical Officer (CMO).